Review Article
Biomarkers for Hepatocellular Carcinoma
Table 2
Various HCC biomarkers and their clinical use.
| HCC marker | Clinical use |
| Alpha-fetoprotein | Early diagnosis, monitoring, and recurrence | Lens culinaris agglutinin reactive AFP (AFP-L3%) | Early diagnosis and prognosis, vascular invasion | Des-gamma-carboxy prothrombin (DCP) | Early diagnosis and prognosis, portal vein invasion and metastasis | Gamma-glutamyl transferase | Early diagnosis complementary to other markers | Alpha-l-fucosidase | Early diagnosis | Glypican-3 | Early diagnosis | Human carbonyl reductase 2 | Prognosis | Golgi phosphoprotein 2 | Tumor aggressiveness | Transforming growth factor beta | Tumor invasiveness | Hepatocyte growth factor (HGF) | Prognosis and disease recurrence | Transforming growth factor-b (TGF-b) | Prognosis invasiveness | Tumor specific growth factor | Diagnosis complementary to other markers | Epidermal growth factor receptor family | Early recurrence | Hepatocyte growth factor | Metastasis reduced survival | Micro RNAs | Tumor spread and survival |
|
|